FDA Determines Regulatory Review Period for Senza Spinal Cord Stimulation System Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the Senza Spinal Cord Stimulation System, a medical device, in accordance with US law, following a submission to the US Patent and Trademark Office (USPTO).